Glooko Diabetes Management

by Glooko  · Based in United States → — Leading Diabetes Management Platform | Glooko We're transforming diabetes across the full continuum of care.
Endocrinology Hospital Medicine Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

Glooko Diabetes Management is a device-agnostic digital health platform designed to centralize and standardize data from diabetes and health monitoring devices. The platform supports synchronization with over 200 brands of blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, and fitness trackers, consolidating fragmented data into unified visualizations.

The platform is built for endocrinologists, primary care physicians, and clinical care teams across outpatient clinics, hospitals, and health systems. It supports both in-person consultations and remote patient monitoring (RPM) initiatives, allowing clinicians to track patient populations and identify trends between visits.

To optimize clinical workflows, Glooko integrates directly with major electronic health record (EHR) systems, including Epic, Oracle Health (Cerner), MEDITECH, and Athenahealth. These integrations utilize SMART on FHIR and HL7 protocols to deliver automated PDF reports and flowsheet statistics directly into the patient chart, reducing manual data entry and eliminating the need to switch between multiple proprietary device platforms.

  • Universal Compatibility: Consolidates data from more than 200 diabetes and health monitoring devices.
  • EHR Integration: Offers single sign-on access and automated data delivery within major EHR systems.
  • Population Health Tools: Features a clinic dashboard to help care teams identify high-risk patients and prioritize interventions.
  • Cloud Connectivity: Enables automatic, continuous data synchronization from connected devices without requiring manual uploads or cables.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Unifies data from over 200 diabetes and health monitoring devices
  • Integrates with EHRs and streamlines clinical workflows
  • Provides actionable insights for healthcare providers
  • Outpatient Glooko Diabetes Management Platform
  • Inpatient EndoTool Glucose Management System for patient-specific insulin dosing
  • Glooko Mobile App for people with diabetes (data syncing, visualizations, remote collaboration)
  • Remote patient monitoring capabilities
  • Optimizes diabetes population health management
  • Multiple top-tier global security and privacy certifications (HITRUST, ISO 27001, SOC 2 Type II/SOC 3)
  • Single Sign-On (SSO) functionality for clinical teams

Use Cases

  • Outpatient diabetes management
  • Inpatient glycemic management
  • Remote patient monitoring and engagement
  • Diabetes population health management for clinics and health systems
  • Personal diabetes management and tracking for patients
  • CMS reporting on inpatient insulin management systems

What Physicians Need to Know

Key Capabilities
Unifies data from over 200 diabetes and health monitoring devices (glucose monitors, insulin pumps, CGMs, fitness trackers, food tracking apps) into a single platform. Provides actionable insights through comprehensive charts and graphs, identifying risks and trends. Offers remote patient monitoring (RPM) and a clinic dashboard for population health management, prioritizing patients by clinical risk using TIDE metrics and CGM data. Supports streamlined clinical workflows and secure data sharing.
Clinical Utility
Enhances clinical efficiency, facilitates informed decision-making, and streamlines care coordination. Improves health outcomes, including reduced HbA1c, decreased average blood glucose, increased in-range blood glucose, and decreased hyperglycemia. Reduces administrative burden, increasing time for direct patient care, and helps mitigate clinician burnout.
Integration Options
Seamlessly integrates with leading EHR systems such as Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, utilizing SMART on FHIR and HL7 for interoperability. Offers Direct API and EHR integration solutions, currently available for US-based customers, supporting over 200 diabetes and health monitoring devices.
Compliance Status
HIPAA Compliant, GDPR Compliant, FDA Registered and 21 CFR Part 11 Compliant. Holds ISO 13485 (Medical Device Quality System Standard) and Regulation (EU) 2017/745 (CE marking) certifications. Also HITRUST certified and has achieved SOC 2 Type II and SOC 3 certifications, demonstrating robust data security and privacy.
Pricing Model
The Glooko mobile app is free for patients. Healthcare providers and clinics should contact a Glooko representative directly for pricing information regarding the RPM platform and professional solutions.
User Experience
Designed for healthcare professionals to enhance efficiency with a unified platform that reduces platform switching. Features a user-friendly clinic dashboard providing at-a-glance insights and a streamlined patient review list. Single Sign-On (SSO) with EHRs like Epic further simplifies access and workflow.
Support Quality
Offers dedicated customer success managers, U.S.-based support, and expert-led implementation. Provides an extensive help center, rapid response times, comprehensive training resources, and a designated Integration Manager during the integration process.
Implementation Complexity
Described by some customers as having a 'low IT hurdle' for implementation. Glooko provides expert-led implementation and dedicated integration managers to support the process. It leverages standard interoperability frameworks (SMART on FHIR, HL7) but requires ADT messages from the customer's EHR for full workflow integration.
Evidence Base
Multiple studies demonstrate that Glooko's RPM leads to immediate and sustained improvements in glycemic outcomes, including reduced HbA1c, decreased average blood glucose, and increased time in range. The clinic dashboard is built on evidence-based TIDE metrics developed by Stanford researchers, with studies showing significant reductions in provider screen time.
Physician Tip

Leverage Glooko's comprehensive data aggregation and EHR integration to gain a holistic view of your diabetes patient population directly within your existing workflow, reducing administrative burden. Utilize the clinic dashboard's risk stratification features to prioritize patient outreach and interventions, focusing on those most in need of immediate attention. Encourage patients to use the free mobile app for self-management and remote data syncing to enhance engagement and provide continuous insights between visits.

Glooko boasts extensive integration capabilities with over 200 diabetes and health monitoring devices, including CGMs, insulin pumps, and BGMs. Its seamless integration with major EHR systems (Epic, Oracle Health, MEDITECH, etc.) via SMART on FHIR and HL7 is a key strength, centralizing data and minimizing platform switching for US-based customers. This broad interoperability is crucial for a unified patient data view.

Details

Category Endocrinology & Metabolic AI, Patient Engagement & Education, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Glooko platform (web and mobile application) is registered with the FDA and has received confirmation of 21 CFR Part 11 compliance. Additionally, the EndoTool Glucose Management System, a Glooko Company product, is an FDA-cleared Class II medical device indicated for inpatient use.
Integrations
EHR Not specified
Specialties Endocrinology, Hospital Medicine, Internal Medicine

What the Web Says

Glooko Diabetes Management is a platform that centralizes diabetes health data from various devices for both patients and healthcare providers, aiming to improve health outcomes through remote monitoring and data insights. Physicians and healthcare IT generally praise its ease of implementation and ability to empower patients, with studies indicating improved glycemic control. However, some users have reported issues with the app's interface, data syncing, and food logging.

Overall: Mixed

Strengths

  • Easy implementation and low IT hurdle for healthcare systems.
  • Empowers patients to better manage their condition.
  • Clinically proven to improve glycemic outcomes, including reduced average blood glucose and hyperglycemia.
  • Compatible with a wide range of diabetes and fitness devices (over 200).
  • Streamlines workflows for care teams by providing pre-populated data and reports.
  • Offers personalized insights and reports for better understanding of diabetes trends.

Limitations

  • App interface can be slow and not user-friendly.
  • Issues with food logging, including difficulty editing imported data, missing custom foods, and a poor food library in some regions.
  • Data syncing problems, particularly with certain devices or between the app and Apple Health.
  • Some users find the app confusing to navigate and extract desired information.
  • Lack of real-time CGM data display in the app, with reported delays.
  • Proprietary cables for data upload were a past concern for some users.

Based on reviews from: Reddit, FeaturedCustomers, App Store (Apple), Google Play Store, Glooko (official website), PMC (PubMed Central), Shortlister, G2

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Glooko Diabetes Management

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Glooko Press Release
Glooko Introduces the First and Only Pump Settings EHR Integration to Bring Insulin Pump Data Directly Into Clinical Workflows
Glooko announced a new integration that brings insulin pump configuration data directly into Electronic Health Record (EHR) flowsheets, aiming to reduce manual documentation for clinicians. This device-agnostic capability is a first-of-its-kind feature designed to streamline clinical workflows.
2026-06
Glooko Press Release
Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud
Glooko received FDA 510(k) clearance for EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform for hospital use. This clearance marks a significant step in scaling glycemic safety and individualized care in inpatient settings.
2026-05
Glooko Press Release
Glooko and mylife Diabetes Care Expand Diabetes Data Management Partnership
Glooko and mylife Diabetes Care expanded their partnership, with Glooko becoming the primary data management platform for mylife products, including the mylife Loop automated insulin delivery solution. This collaboration aims to provide smoother, more connected experiences for users and healthcare teams.
2026-05
Glooko Press Release
Glooko Wins u201cBest Overall MedTech Softwareu201d in 2026 MedTech Breakthrough Awards
Glooko was recognized as the winner of the u201cBest Overall MedTech Softwareu201d award in the 10th annual MedTech Breakthrough Awards program. This award acknowledges Glooko's comprehensive suite of software solutions for diabetes and glycemic management.
2026-05
Glooko Press Release
New EndoTool IV data presented at AACE show virtual elimination of severe hypoglycemia across 19 hospitals
New data presented at AACE 2026 demonstrated that Glooko's EndoTool IV, an inpatient glycemic management solution, virtually eliminated severe hypoglycemia across 19 hospitals. This highlights the solution's effectiveness in improving patient safety.
2026-04
Glooko Press Release
Glooko to Expand EMEA CGM Connectivity with Roche Accu-Cheku00ae SmartGuide Integration
Glooko announced the integration of its diabetes management platform with the Roche Accu-Chek SmartGuide CGM solution across select European countries. This expansion aims to enhance CGM connectivity in the EMEA region.
2026-03
Glooko Blog
New Glooko Web 25.2 and Mobile 6.12 Release Introduces New Clinic Dashboard and Updated Tools to Enhance Diabetes Management
Glooko's latest software release, Web 25.2 and Mobile 6.12, introduces a new clinic dashboard and updated tools to streamline workflows and provide insights into population health trends. These enhancements aim to improve data visualization and decision-making for healthcare providers.
2025-09
PMC (Journal of Diabetes Science and Technology)
Remote glucose monitoring is feasible for patients and providers using a commercially available population health platform
A study published in the Journal of Diabetes Science and Technology demonstrated the feasibility of remote patient monitoring (RPM) using the Glooko Population Health platform for youth with Type 1 Diabetes. The study found RPM to be helpful for patients and associated with improved glycemic control.
2023-02

Videos

Product demos, reviews, and walkthroughs for Glooko Diabetes Management.

View all on YouTube

Frequently Asked Questions

Glooko utilizes machine learning and AI capabilities to analyze patient data, providing insights into trends and patterns that impact glucose levels. This helps physicians understand patient behavior and make more informed treatment decisions. The platform aggregates data from over 200 diabetes and health monitoring devices, offering actionable insights and streamlining clinical workflows for a holistic view of patient health.
Glooko maintains rigorous compliance with global data privacy and security standards, including HIPAA, GDPR, ISO 27001, SOC 2 Type II/SOC 3, HITRUST r2, ISO 13485, FDA registration (21 CFR Part 11), and EU MDR (CE marking). They employ encryption for data storage and transactions on secure servers, with robust controls validated through annual third-party audits to protect sensitive patient information.
While Glooko uses machine learning for insights, specific limitations of its AI algorithms regarding biases or accuracy in diverse populations are not explicitly detailed in available information. However, general concerns in healthcare AI include potential algorithmic bias from unrepresentative training data, measurement bias (e.g., CGM accuracy varying with skin tone), and a lack of robust equity evaluation across different demographic subgroups. It is also noted that patient outcomes can decline if Glooko use is discontinued.
Glooko integrates with leading EHR systems such as Epic, Oracle Health, MEDITECH, and Athenahealth, utilizing HL7 v2-based integrations and SMART on FHIR technology for secure data exchange. This integration aims to centralize diabetes data within the EHR, eliminating the need for multiple logins or manual data transfers and thereby streamlining clinical workflows and reducing administrative burden for physicians.
Physicians might consider alternatives such as Livongo, mySugr, Dexcom Clarity, Abbott LibreView, Diabetes:M, and GluKee. Glooko is primarily a clinical-grade platform designed for healthcare systems to manage patient data at scale, while some alternatives like mySugr and GluKee are often more focused on personal diabetes tracking and patient engagement.
The Glooko mobile app is free for individual patients to download and use for self-management. For healthcare providers, pricing for the Remote Patient Monitoring (RPM) platform requires direct contact with a Glooko representative. Pricing is generally based on the duration and terms of the contract with the vendor, and additional AWS infrastructure costs may apply.

Related Tools

Virta Health
Virta Health
Endocrinology & Metabolic AI
Virta Health offers a virtual health program focused on reversing Type 2 diabetes, prediabetes, and obesity through a nutrition-first approach, continuous remote care, and personalized coaching.
Hybrid
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.
Varies
UpDoc Inc.
UpDoc Inc.
Clinical Decision Support & Reference
UpDoc is an FDA-cleared, enterprise-ready agentic clinical AI platform that integrates with EHRs to deploy AI agents for continuous, physician-governed care-related tasks, especially for chronic disease management.
Tiered subscription
GlucoSense
GlucoSense
Endocrinology & Metabolic AI
GlucoSense is an AI-powered CGM intelligence platform that provides personalized insights for individuals with diabetes and tools for population health management for healthcare providers and health plans. It integrates with various CGMs and wearables to offer real-time monitoring, AI-driven food logging, and simplified care team workflows.
Freemium
Endobits
Bio-Conscious Technologies Inc.
Clinical Decision Support & Reference
Endobits is an automated decision-support platform for diabetes and metabolic health that collects real-time data from various devices, EMRs, and EHRs to triage patients and prioritize those needing intervention.
$99 per patient per month for practices under 1,000 patients on service; volume pricing above that.
StackAI for Endocrinology Practices
StackAI
Documentation & Scribing
StackAI helps endocrinology practices deploy secure AI agents that automate patient support, summarize clinical context, and streamline document-driven workflows with enterprise governance and HIPAA-ready controls.
Freemium

See all Endocrinology & Metabolic AI tools →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21

Investors who backed Glooko Diabetes Management

Funded through the company that built this tool.

Health Catalyst Capital
PE T3
New York, United States
$1M-$5M
Health Catalyst Capital is a healthcare-dedicated investment firm focused on healthcare technology, services, and digital health businesses, with a thesis built around…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.